AvaALL: Bevacizumab Beyond Progression in Patients with Metastatic Non-Squamous NSCLC

Viola Zhu, MD, PhD of UC Irvine Health discusses the AvaALL trial and the use of bevacizumab beyond progression in patients with non-small cell lung cancer. This was recorded at the 2017 MOASC Spotlig... Author: moasc Added: 08/02/2017
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts